Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy

BACKGROUND: Recurrent glioblastoma multiforme (GBM) is a highly aggressive primary malignant brain tumor that is resistant to existing treatments. Recently, we reported that activated autologous natural killer (NK) cell therapeutics induced a marked increase in survival of some patients with recurre...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Sohyun, Lim, Jaejoon, Kang, Haeyoun, Jeong, Ju-Yeon, Joung, Je-Gun, Heo, Jinhyung, Jung, Daun, Cho, Kyunggi, An, Hee Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875464/
https://www.ncbi.nlm.nih.gov/pubmed/36694264
http://dx.doi.org/10.1186/s13578-023-00961-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875464/
https://www.ncbi.nlm.nih.gov/pubmed/36694264
http://dx.doi.org/10.1186/s13578-023-00961-4

Ejemplares similares